IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3033 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed118    
    Printed0    
    Emailed0    
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL CONTRIBUTION
Year : 1987  |  Volume : 53  |  Issue : 6  |  Page : 332--334

Multidrug Therapy in Pemphigus Vulgaris



Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 28145346

Rights and PermissionsRights and Permissions

Twenty four patients having pemphigus vulgaris were treated with combined drug therapy consisting of oral prednisolone 1 mg per Kg body weight, cyclophosphamide 2.5 mg per Kg body weight and methotrexate 2.5 mg biweekly. The drugs were gradually tapered off to achieve a minimum maintainence dose of 10-15 mg prednisolone on alternate days at the end of 2 years of observation. The age groups of patients varied from 15 to 78 years. Maximum cases were between 31 to 50 years. There were 15 males and 9 females. T he duration of disease varied from 4 months to over 36 months at the time of reporting. Number of episodes recorded at the time of first presentation were one episodes in 6( 25%) and mutiple episodes in 18 (75%). The period of observation varied from 6 months to 27 months. Two patients relapsed at the time of observation. There has been remarkable response to treatment in the form of quick recovery from lesions without any significant side effects.






[PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow